Nifty
:
23850.90
Sensex
:
78782.24
-453.45 (-1.87%)
-606.82 (-0.76%)
Nifty
Sensex
:
:
23850.90
78782.24
-453.45 (-1.87%)
-606.82 (-0.76%)

Max Healthcare Institute Ltd.

Hospital & Healthcare Services

Rating :
N/A

BSE: 543220 | NSE: MAXHEALTH

NSE BSE
913.80
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  913.00
  •  925.00
  •  910.20
  •  917.80
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1337555
  •  12245.37
  •  1118.00
  •  570.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,00,416.38
  • 95.29
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,00,466.73
  • 0.15%
  • 11.71

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 23.74%
  • 0.16%
  • 3.18%
  • FII
  • DII
  • Others
  • 57.29%
  • 14.45%
  • 1.18%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.91
  • 38.55
  • 11.15

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 34.72
  • 73.73
  • 9.56

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 141.37
  • 20.46

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 62.86

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 7.47

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 40.75

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Net Sales
1,542.95
1,284.99
20.07%
1,422.90
1,214.51
17.16%
1,334.97
1,141.78
16.92%
1,363.16
1,139.44
19.63%
Expenses
1,155.54
947.61
21.94%
1,041.37
874.17
19.13%
949.11
827.79
14.66%
975.81
818.20
19.26%
EBITDA
387.41
337.38
14.83%
381.53
340.34
12.10%
385.86
313.99
22.89%
387.35
321.24
20.58%
EBIDTM
25.11%
26.26%
26.81%
28.02%
28.90%
27.50%
28.42%
28.19%
Other Income
34.68
41.32
-16.07%
45.25
40.22
12.51%
46.02
44.61
3.16%
45.48
23.50
93.53%
Interest
23.88
19.39
23.16%
20.73
19.53
6.14%
11.24
20.13
-44.16%
8.53
21.84
-60.94%
Depreciation
76.90
55.82
37.76%
70.32
60.35
16.52%
60.96
57.03
6.89%
57.88
57.68
0.35%
PBT
321.31
303.49
5.87%
335.73
300.68
11.66%
359.68
281.44
27.80%
366.42
265.22
38.16%
Tax
85.04
63.41
34.11%
84.19
49.76
69.19%
70.34
59.03
19.16%
89.74
-192.13
-
PAT
236.27
240.08
-1.59%
251.54
250.92
0.25%
289.34
222.41
30.09%
276.68
457.35
-39.50%
PATM
15.31%
18.68%
17.68%
20.66%
21.67%
19.48%
20.30%
40.14%
EPS
2.43
2.47
-1.62%
2.59
2.58
0.39%
2.98
2.29
30.13%
2.85
4.72
-39.62%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 16
Mar 15
Mar 14
Net Sales
5,663.98
5,406.02
4,562.60
3,936.55
2,507.97
1,059.03
1,691.02
1,445.40
1,133.61
944.46
Net Sales Growth
18.48%
18.49%
15.90%
56.96%
136.82%
-37.37%
16.99%
27.50%
20.03%
 
Cost Of Goods Sold
1,169.23
1,118.52
922.01
922.90
594.41
217.31
364.46
398.63
345.95
328.00
Gross Profit
4,494.75
4,287.50
3,640.59
3,013.65
1,913.56
841.72
1,326.56
1,046.77
787.66
616.46
GP Margin
79.36%
79.31%
79.79%
76.56%
76.30%
79.48%
78.45%
72.42%
69.48%
65.27%
Total Expenditure
4,121.83
3,924.88
3,335.14
2,998.14
2,124.34
965.45
1,545.51
1,329.79
1,058.39
914.52
Power & Fuel Cost
-
77.54
69.04
62.67
51.37
22.72
46.06
40.73
32.60
29.63
% Of Sales
-
1.43%
1.51%
1.59%
2.05%
2.15%
2.72%
2.82%
2.88%
3.14%
Employee Cost
-
934.40
809.35
759.92
588.78
230.13
440.55
297.48
232.09
188.81
% Of Sales
-
17.28%
17.74%
19.30%
23.48%
21.73%
26.05%
20.58%
20.47%
19.99%
Manufacturing Exp.
-
1,348.42
1,195.50
995.21
670.35
336.05
112.01
16.97
293.99
244.08
% Of Sales
-
24.94%
26.20%
25.28%
26.73%
31.73%
6.62%
1.17%
25.93%
25.84%
General & Admin Exp.
-
382.92
303.70
226.23
165.14
129.84
563.52
476.29
142.24
114.53
% Of Sales
-
7.08%
6.66%
5.75%
6.58%
12.26%
33.32%
32.95%
12.55%
12.13%
Selling & Distn. Exp.
-
0.00
0.00
0.00
0.00
0.00
0.00
28.30
0.00
0.00
% Of Sales
-
0%
0%
0%
0%
0%
0%
1.96%
0%
0%
Miscellaneous Exp.
-
63.08
35.54
31.21
54.29
29.40
18.91
99.69
11.52
9.47
% Of Sales
-
1.17%
0.78%
0.79%
2.16%
2.78%
1.12%
6.90%
1.02%
1.00%
EBITDA
1,542.15
1,481.14
1,227.46
938.41
383.63
93.58
145.51
115.61
75.22
29.94
EBITDA Margin
27.23%
27.40%
26.90%
23.84%
15.30%
8.84%
8.60%
8.00%
6.64%
3.17%
Other Income
171.43
189.05
152.31
131.51
134.97
48.08
66.72
29.78
27.27
23.48
Interest
64.38
59.89
83.86
100.87
179.46
83.24
101.27
73.06
61.16
62.25
Depreciation
266.06
244.98
232.19
221.12
174.09
45.64
102.64
86.62
78.38
55.46
PBT
1,383.14
1,365.32
1,063.72
747.93
165.05
12.78
8.32
-14.29
-37.05
-64.29
Tax
329.31
307.68
-39.79
133.85
45.85
-0.13
8.51
-0.02
0.00
0.36
Tax Rate
23.81%
22.54%
-3.74%
18.11%
-66.79%
-1.02%
102.28%
0.14%
0.00%
-0.56%
PAT
1,053.83
1,057.64
1,103.51
605.05
-114.50
12.91
-3.01
-13.77
-37.05
-64.65
PAT before Minority Interest
1,053.83
1,057.64
1,103.51
605.05
-114.50
12.91
-0.19
-14.27
-37.05
-64.65
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
-2.82
0.50
0.00
0.00
PAT Margin
18.61%
19.56%
24.19%
15.37%
-4.57%
1.22%
-0.18%
-0.95%
-3.27%
-6.85%
PAT Growth
-9.99%
-4.16%
82.38%
-
-
-
-
-
-
 
EPS
10.84
10.88
11.35
6.22
-1.18
0.13
-0.03
-0.14
-0.38
-0.67

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Shareholder's Funds
8,408.14
7,409.59
6,282.47
5,638.68
2,553.15
963.19
Share Capital
971.91
970.92
969.61
965.95
537.24
537.24
Total Reserves
7,368.75
6,397.04
5,290.74
4,646.22
2,015.91
425.95
Non-Current Liabilities
2,343.09
1,646.69
2,149.39
2,127.85
410.56
1,251.32
Secured Loans
1,060.33
496.08
628.91
842.32
105.73
889.10
Unsecured Loans
0.50
0.50
0.50
0.50
0.50
0.96
Long Term Provisions
75.47
60.48
59.79
60.19
40.66
18.02
Current Liabilities
1,248.71
1,045.57
757.27
776.93
1,009.95
1,140.03
Trade Payables
677.47
543.46
444.11
435.69
179.63
291.59
Other Current Liabilities
448.80
408.16
196.95
237.52
95.26
752.87
Short Term Borrowings
61.29
45.58
74.53
54.25
727.37
77.61
Short Term Provisions
61.15
48.37
41.68
49.47
7.69
17.96
Total Liabilities
11,999.94
10,101.85
9,189.13
8,543.46
3,973.66
3,354.54
Net Block
8,720.66
7,038.70
7,017.58
6,536.38
850.95
2,192.37
Gross Block
9,902.43
7,958.37
7,759.60
7,099.22
1,252.16
2,557.37
Accumulated Depreciation
1,181.77
919.67
742.02
562.84
401.21
365.00
Non Current Assets
10,293.76
8,158.78
8,188.84
7,418.99
1,058.27
2,907.24
Capital Work in Progress
553.04
252.43
151.12
26.93
27.55
87.02
Non Current Investment
2.12
0.51
0.51
0.51
0.00
0.51
Long Term Loans & Adv.
727.51
673.93
757.17
679.63
70.06
535.51
Other Non Current Assets
227.40
193.21
262.46
175.54
109.71
91.83
Current Assets
1,706.18
1,943.07
1,000.29
1,124.47
2,915.39
447.30
Current Investments
0.00
0.00
0.00
0.00
2,182.06
0.00
Inventories
79.84
76.23
61.36
53.80
26.80
26.01
Sundry Debtors
462.69
336.12
385.36
365.89
96.09
362.61
Cash & Bank
1,099.27
1,468.07
499.31
652.92
119.57
11.64
Other Current Assets
64.38
14.06
23.99
14.47
490.87
47.04
Short Term Loans & Adv.
40.79
48.59
30.27
37.39
478.76
36.06
Net Current Assets
457.47
897.50
243.02
347.54
1,905.44
-692.73
Total Assets
11,999.94
10,101.85
9,189.13
8,543.46
3,973.66
3,354.54

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Cash From Operating Activity
1,121.80
1,284.13
740.52
117.86
77.09
88.95
PBT
1,365.32
1,063.72
738.90
-68.65
12.78
8.32
Adjustment
184.85
225.84
241.22
504.74
109.44
156.89
Changes in Working Capital
-159.09
155.69
-130.54
-376.25
-38.84
-48.13
Cash after chg. in Working capital
1,391.08
1,445.25
849.58
59.84
83.38
117.08
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-269.28
-161.12
-109.06
58.02
-6.29
-28.13
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-1,285.45
-102.32
-763.80
-73.00
-2,640.70
-16.53
Net Fixed Assets
-450.48
-140.69
-1,687.37
-2,982.65
557.88
Net Investments
-440.62
-27.73
932.29
91.94
-1,701.27
Others
-394.35
66.10
-8.72
2,817.71
-1,497.31
Cash from Financing Activity
-263.74
-288.56
-294.17
191.33
2,353.12
-73.95
Net Cash Inflow / Outflow
-427.39
893.25
-317.45
236.19
-210.49
-1.53
Opening Cash & Equivalents
1,374.33
480.97
626.59
111.01
321.50
9.13
Closing Cash & Equivalent
979.84
1,374.33
309.14
626.59
111.01
7.60

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Book Value (Rs.)
85.82
75.89
64.57
58.10
47.52
17.93
ROA
9.57%
11.44%
6.82%
-1.83%
0.35%
-0.01%
ROE
13.47%
16.19%
10.19%
-2.80%
0.73%
-0.02%
ROCE
16.26%
15.32%
12.38%
2.22%
3.57%
5.32%
Fixed Asset Turnover
0.61
0.58
0.53
0.60
0.56
0.67
Receivable days
26.97
28.86
34.83
33.62
79.05
66.97
Inventory Days
5.27
5.50
5.34
5.87
9.10
5.86
Payable days
199.21
195.48
173.98
188.92
99.45
94.83
Cash Conversion Cycle
-166.97
-161.11
-133.81
-149.44
-11.30
-22.01
Total Debt/Equity
0.14
0.08
0.12
0.16
0.33
1.05
Interest Cover
23.80
13.68
8.33
0.62
1.15
1.08

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015

News Update:


  • Max Healthcare Institute to acquire 63.65% stake in Jaypee Healthcare
    27th Sep 2024, 10:12 AM

    The company has executed SPA with Jaypee Infratech and Lakshdeep Group for acquisition

    Read More
  • Max Healthcare Institute enters into strategic collaboration with Lakshdeep Group
    13th Sep 2024, 15:44 PM

    This Strategic Collaboration and proposed acquisition will give the company a controlling stake in JHL, including its flagship asset, the renowned 500-beds Jaypee Hospital, Noida

    Read More
  • Max Healthcare to ink lease arrangement with Silicon Constructions for hospital in Punjab
    1st Aug 2024, 15:57 PM

    The board of directors of the Company at their meeting held on August 1, 2024, approved the same

    Read More
  • Max Healthcare’s arm gets nod to acquire additional equity stake Starlit Medical Centre
    1st Aug 2024, 15:28 PM

    The Board of Directors of the company, in meeting held on August 1, 2024 has approved the same

    Read More
  • Max Healthcare Inst - Quarterly Results
    1st Aug 2024, 14:02 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.